Skip to main content
Premium Trial:

Request an Annual Quote

Qlucore to Use Swedish Government Grant to Develop NGS Capabilities for Omics Explorer


Qlucore said this week that it will use a grant from the Swedish government to develop next-generation sequence data analysis capabilities for Omics Explorer — the company's software for analyzing data from gene expression, proteomic, DNA methylation, protein array, and miRNA experiments.

The firm intends to build a new product module for Omics Explorer that will enable fast and interactive analysis of NGS data and will also appeal to a broader audience instead of just bioinformaticians and statisticians. They plan to release the first version of Omics Explorer that includes NGS capabilities next year.

In an email, Carl-Johan Ivarsson, Qlucore's president, told BioInform that although the company is still deciding on what capabilities to incorporate into Omics Explorer, the final product will likely include "new ways of visualizing data" as well as "filters and detection algorithms for a range of biological[ly] relevant questions such as deletions, insertions, translocations, fusion genes [and more]."

He also said that the company opted to extend its existing product rather than develop a separate solution so that customers can use the same tool to analyze different data types.

The grant was provided by Vinnova, the Swedish Governmental Agency for Innovation Systems, which supports small and medium-sized enterprises through its Research and Grow program.

Qlucore declined to disclose details about the exact amount of the grant.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.